Nonimmunologic Hydrops Fetalis and Chromosome Aberration
Hirotaka Maeda, Hiroshi Shimokawa, Toshiko MATSUO, S Hisanaga, Hitoo Nakano
Abstract
Hirotaka Maeda, Hiroshi Shimokawa, Toshiko MATSUO, S Hisanaga, Hitoo Nakano
Abstract
Abstract In order to evaluate the role of genetic amniocentesis for the management of nonimmunologic hydrops fetalis (NIHF), the present study was performed. In 29 cases with NIHF, diagnosed antenatally using ultrasound, a genetic amniocentesis was performed. Three cases had chromosome aberration and all were 21 trisomy; one had a heart anomaly and the other 2 cases had no malformations. All 3 cases died during the neonatal period in spite of intensive perinatal management. Among NIHF, the incidence of 21 trisomy is 10%. Genetic amniocentesis is an invaluable means to detect underlying diseases in NIHF.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract In order to evaluate the role of genetic amniocentesis for the management of nonimmunologic hydrops fetalis (NIHF), the present study was performed. In 29 cases with NIHF, diagnosed antenatally using ultrasound, a genetic amniocentesis was performed. Three cases had chromosome aberration and all were 21 trisomy; one had a heart anomaly and the other 2 cases had no malformations. All 3 cases died during the neonatal period in spite of intensive perinatal management. Among NIHF, the incidence of 21 trisomy is 10%. Genetic amniocentesis is an invaluable means to detect underlying diseases in NIHF.
Key concepts: Hydrops fetalis, Amniocentesis, Trisomy, Obstetrics, Medicine, Chromosome aberration, Prenatal diagnosis, Chromosome